Eli Lilly clarifies Mounjaro availability

Manufacturer moves to correct inaccurate reporting on the availability of Mounjaro   Mandatory shortage reporting requirements for glucagon-like peptide-1 receptor agonist (GLP-1 RA) medicines is causing confusion about the availability of Mounjaro (tirzepatide), manufacturer, Eli Lilly says.  The company said the Therapeutic Goods Administration’s (TGA) reporting requirements had “resulted in inaccurate reporting of the actual